NASDAQ: EVO
Evotec Se Stock Ownership - Who owns Evotec Se?

Insider buying vs selling

Have Evotec Se insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVO insiders and whales buy or sell their stock.

EVO Shareholders

What type of owners hold Evotec Se stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mubadala Investment Co Pjsc2.59%4,597,701$18.11MInstitution
Wellington Management Group LLP1.07%1,903,401$7.50MInstitution
Blackrock Inc0.86%1,522,664$6.00MInstitution
Dcf Advisers LLC0.42%751,579$2.96MInstitution
Morgan Stanley0.05%88,041$346.88kInstitution
Abc Arbitrage Sa0.04%77,919$307.00kInstitution
Tower Research Capital LLC Trc0.02%41,185$162.27kInstitution
Lighthouse Investment Partners LLC0.02%37,545$147.93kInstitution
Fore Capital LLC0.01%17,005$67.00kInstitution
Ubs Group Ag0.01%13,620$53.66kInstitution

1 of 3

EVO vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVO5.12%0.00%
INDV56.37%0.00%
ANIP26.63%73.37%Net SellingNet Selling
PCRX64.98%35.02%Net Selling
AMPH47.49%52.51%Net BuyingNet Buying

Evotec Se Stock Ownership FAQ

Who owns Evotec Se?

Evotec Se (NASDAQ: EVO) is owned by 5.12% institutional shareholders, 0.00% Evotec Se insiders, and 94.88% retail investors. Mubadala Investment Co Pjsc is the largest individual Evotec Se shareholder, owning 4.60M shares representing 2.59% of the company. Mubadala Investment Co Pjsc's Evotec Se shares are currently valued at $18.67M.

If you're new to stock investing, here's how to buy Evotec Se stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.